APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
批准号:
10170188
负责人:
RADOSVETA KOLDAMOVA
金额:
$63.28万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-05-31
关键词:
ATP-Binding Cassette TransportersAcuteAdrenal GlandsAffectAffinityAgingAllelesAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid depositionApolipoprotein EAstrocytesAutophagocytosisAutopsyBindingBiological MarkersBiologyBrainCardiovascular DiseasesCell physiologyCholesterolChromosome 19CodeCognitionCognitive deficitsDataDiseaseEarly DiagnosisEpigenetic ProcessExhibitsGene ClusterGene ExpressionGene Expression ProfileGenesGenotypeGoalsHigh Density LipoproteinsHistonesHomeostasisHumanHuman PathologyHypolipoproteinemiaImmunologic ReceptorsImpaired cognitionImpairmentInflammationInjectionsInterventionLate Onset Alzheimer DiseaseLipidsLipoproteinsLow Density Lipoprotein ReceptorLow-Density LipoproteinsMammalian CellMediatingMetabolicMicrogliaMitochondriaMolecularMolecular ProfilingMolecular TargetMusNerve DegenerationNetwork-basedNeurogliaNeuronsPathogenesisPathologicPatientsPhagocytosisPhenotypePhospholipidsPhysiologyPopulationProcessProtein IsoformsRegulationReportingResearchRiskRoleSamplingSignal TransductionSurfaceTechnologyTestingTweensVery low density lipoproteinage effectage relatedaging brainapolipoprotein E-4basebrain cellcell typecognitive performancedifferential expressionepigenomegenetic risk factorhigh riskimmune functionlipidomelipidomicsmind controlnext generation sequencingnovel therapeutic interventionparticlepreventprotective effectprotein degradationreceptor bindingtranscriptometranscriptomicsuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The inheritance of APOEε4 allele is the strongest genetic risk factor for late onset Alzheimer’s disease (LOAD).
In fact, the inheritance of APOEε4 allele is the strongest known genetic risk factor in human pathology, but the
mechanism is poorly understood. In contrast, APOEε2 allele is protective for AD and age-related diseases AD.
While APOE has been associated with critical cellular functions such as oxidative processes, inflammation, glial
cell and neuronal homeostasis, none of those can be dissociated from binding, transport and delivery of choles-
terol and phospholipids to different cell types by APOE containing lipoprotein particles. It is also uniformly ac-
cepted that the above functions are APOE-isoform specific. Our preliminary data demonstrates that phospholipid
composition of APOEε3/3 and APOEε4/4 AD brain differs significantly. Most prominent were changes in lipid
classes that are critical in regulation of normal mitochondrial function and dynamics, but also in execution of
metabolic cascades part of regulated intracellular protein degradation known as autophagy and mitophagy. We
also found significant APOE isoform-specific differences between the transcriptomic profiles of the AD samples
that substantiate molecular explanation of specific AD pathological changes in brain, based on perturbed gene
expression. Our preliminary data also demonstrates that there is a significant difference in the phospholipid
content of native APOE2, APOE3- and APOE4- lipoproteins suggesting that that they may affect differentially
surface immune receptors and initiate different signal transduction cascades.
We hypothesize that the APOE isoform-specific effects on phenotype are driven by the different phospholipid
composition of APOE lipid particles and/or by the differential effect of APOE isoforms on brain transcriptome and
lipidome. In the First SA, we will establish the association of APOE alleles with AD brain transcriptome and
lipidome and determine the allele specific impact on mitochondrial function and dynamics. We will use postmor-
tem brain samples from AD patients and controls of different APOE genotypes to determine differences in tran-
scriptomes and lipidomes within and between genotypes. We will generate and analyze correlated/co-expressed
gene networks based on APOE allele associated differentially expressed genes and perform correlation analyses
to identify associations between genes and lipids in brain. In the Second SA, we will investigate APOE isoform-
dependent epigenetic and transcriptomic changes in AD brain and APOE Targeted Replacement mice. We will
determine the enrichment of histone marks in specific cell types isolated from human AD and control brains
and will examine APOE allele specific correlations to gene expression profiles. Next, we will examine the
effect of aging on epigenome and transcriptome in distinct brain cell types of human APOE TR mice. In the
Third SA, we will determine how APOE2 lipoproteins counteract the acute deleterious effects of A. The goals
are to examine the effect of APOE2, E3 and E4 lipoproteins on: transcriptome of distinct brain cell populations
and cognition in mice following intracranial injection of A
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
-
批准号:10447273
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2022
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
-
批准号:10634661
-
项目类别:
-
资助金额:$72.98万
-
财政年份:2022
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
ncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkers
-
批准号:10532000
-
项目类别:
-
资助金额:$229.75万
-
财政年份:2022
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
-
批准号:10450775
-
项目类别:
-
资助金额:$63.59万
-
财政年份:2018
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
APOE orchestrated ''molecular signatures'' in aging brain and AD - the contribution of APOE2
-
批准号:9555298
-
项目类别:
-
资助金额:$44.06万
-
财政年份:2017
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Epigenetic and phenotypic effects of arsenic: impacts on cognition and AD
-
批准号:8755745
-
项目类别:
-
资助金额:$50.66万
-
财政年份:2014
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
-
批准号:8103681
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2011
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
-
批准号:8484324
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2011
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
-
批准号:8277207
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2011
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
-
批准号:8850760
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2011
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
-
批准号:8665344
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2011
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
-
批准号:8661887
-
项目类别:
-
资助金额:$5.53万
-
财政年份:2011
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Role of ABCA1 in neurodegeneration
-
批准号:7339645
-
项目类别:
-
资助金额:$25.39万
-
财政年份:2007
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Role of ABCA1 in neurodegeneration
-
批准号:8020954
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2007
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Role of ABCA1 in neurodegeneration
-
批准号:7793486
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2007
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Role of ABCA1 in neurodegeneration
-
批准号:7197554
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2007
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Role of ABCA1 in neurodegeneration
-
批准号:7569481
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2007
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
Role of ABCA1 in neurodegeneration
-
批准号:8019715
-
项目类别:
-
资助金额:$3.4万
-
财政年份:2007
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
ABCA1: A Potential Therapeutic Target for AD
-
批准号:7013586
-
项目类别:
-
资助金额:$14.4万
-
财政年份:2005
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
ABCA1: A Potential Therapeutic Target for AD
-
批准号:6868579
-
项目类别:
-
资助金额:$17.1万
-
财政年份:2005
-
负责人:RADOSVETA KOLDAMOVA
-
依托单位:
海外基金